Adult Vaccine Market Size, Trends, Analysis, and Outlook By Type (Monovalent, multivalent), By Application (Influenza, Tetanus/Diphtheria/Pertussis, Varicella, Human Papillomavirus, Zoster, Measles/mumps/Rubella, Pneumococcal, Hepatitis, COVID-19, Others), By Technology (Live Attenuated Vaccines, Inactivated Viral/Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Adult Vaccine market size is poised to register 8.55% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Adult Vaccine market across By Type (Monovalent, multivalent), By Application (Influenza, Tetanus/Diphtheria/Pertussis, Varicella, Human Papillomavirus, Zoster, Measles/mumps/Rubella, Pneumococcal, Hepatitis, COVID-19, Others), By Technology (Live Attenuated Vaccines, Inactivated Viral/Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others).
The Adult Vaccine Market is characterized by efforts to improve vaccination rates, address unmet vaccine needs, and expand immunization recommendations for adults. Vaccines play a critical role in preventing infectious diseases and reducing the burden of vaccine-preventable illnesses across all age groups. Key trends include the development of new vaccines targeting emerging infectious diseases, such as COVID-19 variants, as well as innovative vaccine formulations, delivery methods, and adjuvants to enhance immunogenicity and durability of immune responses. Additionally, there is a growing focus on vaccination as a preventive healthcare measure, with public health campaigns, employer-sponsored vaccination programs, and vaccine mandates driving demand for adult immunization services. Moreover, advancements in vaccine technology, vaccine hesitancy mitigation strategies, and healthcare infrastructure are essential for achieving optimal vaccine coverage and herd immunity, safeguarding public health and mitigating the impact of infectious disease outbreaks.
Adult Vaccine Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Adult Vaccine market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Adult Vaccine survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Adult Vaccine industry.
Key market trends defining the global Adult Vaccine demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Adult Vaccine Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Adult Vaccine industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Adult Vaccine companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Adult Vaccine industry
Leading Adult Vaccine companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Adult Vaccine companies.
Adult Vaccine Market Study- Strategic Analysis Review
The Adult Vaccine market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Adult Vaccine industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Adult Vaccine Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Adult Vaccine Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Adult Vaccine market segments. Similarly, Strong end-user demand is encouraging Canadian Adult Vaccine companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Adult Vaccine market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Adult Vaccine Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Adult Vaccine industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Adult Vaccine market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Adult Vaccine Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Adult Vaccine in Asia Pacific. In particular, China, India, and South East Asian Adult Vaccine markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Adult Vaccine Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Adult Vaccine Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Adult Vaccine market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Adult Vaccine.
Adult Vaccine Market Company Profiles
The global Adult Vaccine market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AstraZeneca, Bharat Biotech, Biological E Ltd, CSL Ltd, GSK plc, Indian Immunologicals Ltd, Johnson & Johnson Services Inc, Pfizer Inc, Sanofi, Serum Institute of India Pvt. Ltd
Recent Adult Vaccine Market Developments
The global Adult Vaccine market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Adult Vaccine Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Type
Monovalent
multivalent
By Application
Influenza
Tetanus/Diphtheria/Pertussis
Varicella
Human Papillomavirus
Zoster
Measles/mumps/Rubella
Pneumococcal
Hepatitis
COVID-19
Others
By Technology
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
Geographical Segmentation:
AstraZeneca
Bharat Biotech
Biological E Ltd
CSL Ltd
GSK plc
Indian Immunologicals Ltd
Johnson & Johnson Services Inc
Pfizer Inc
Sanofi
Serum Institute of India Pvt. Ltd
Formats Available: Excel, PDF, and PPT
The Adult Vaccine Market is characterized by efforts to improve vaccination rates, address unmet vaccine needs, and expand immunization recommendations for adults. Vaccines play a critical role in preventing infectious diseases and reducing the burden of vaccine-preventable illnesses across all age groups. Key trends include the development of new vaccines targeting emerging infectious diseases, such as COVID-19 variants, as well as innovative vaccine formulations, delivery methods, and adjuvants to enhance immunogenicity and durability of immune responses. Additionally, there is a growing focus on vaccination as a preventive healthcare measure, with public health campaigns, employer-sponsored vaccination programs, and vaccine mandates driving demand for adult immunization services. Moreover, advancements in vaccine technology, vaccine hesitancy mitigation strategies, and healthcare infrastructure are essential for achieving optimal vaccine coverage and herd immunity, safeguarding public health and mitigating the impact of infectious disease outbreaks.
Adult Vaccine Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Adult Vaccine market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Adult Vaccine survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Adult Vaccine industry.
Key market trends defining the global Adult Vaccine demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Adult Vaccine Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Adult Vaccine industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Adult Vaccine companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Adult Vaccine industry
Leading Adult Vaccine companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Adult Vaccine companies.
Adult Vaccine Market Study- Strategic Analysis Review
The Adult Vaccine market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Adult Vaccine industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Adult Vaccine Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Adult Vaccine Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Adult Vaccine market segments. Similarly, Strong end-user demand is encouraging Canadian Adult Vaccine companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Adult Vaccine market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Adult Vaccine Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Adult Vaccine industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Adult Vaccine market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Adult Vaccine Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Adult Vaccine in Asia Pacific. In particular, China, India, and South East Asian Adult Vaccine markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Adult Vaccine Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Adult Vaccine Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Adult Vaccine market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Adult Vaccine.
Adult Vaccine Market Company Profiles
The global Adult Vaccine market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AstraZeneca, Bharat Biotech, Biological E Ltd, CSL Ltd, GSK plc, Indian Immunologicals Ltd, Johnson & Johnson Services Inc, Pfizer Inc, Sanofi, Serum Institute of India Pvt. Ltd
Recent Adult Vaccine Market Developments
The global Adult Vaccine market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Adult Vaccine Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Type
Monovalent
multivalent
By Application
Influenza
Tetanus/Diphtheria/Pertussis
Varicella
Human Papillomavirus
Zoster
Measles/mumps/Rubella
Pneumococcal
Hepatitis
COVID-19
Others
By Technology
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AstraZeneca
Bharat Biotech
Biological E Ltd
CSL Ltd
GSK plc
Indian Immunologicals Ltd
Johnson & Johnson Services Inc
Pfizer Inc
Sanofi
Serum Institute of India Pvt. Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Adult Vaccine Market Overview and Key Findings, 2024
1.2 Adult Vaccine Market Size and Growth Outlook, 2021- 2030
1.3 Adult Vaccine Market Growth Opportunities to 2030
1.4 Key Adult Vaccine Market Trends and Challenges
1.4.1 Adult Vaccine Market Drivers and Trends
1.4.2 Adult Vaccine Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Adult Vaccine Companies
2. ADULT VACCINE MARKET SIZE OUTLOOK TO 2030
2.1 Adult Vaccine Market Size Outlook, USD Million, 2021- 2030
2.2 Adult Vaccine Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ADULT VACCINE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ADULT VACCINE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Monovalent
multivalent
By Application
Influenza
Tetanus/Diphtheria/Pertussis
Varicella
Human Papillomavirus
Zoster
Measles/mumps/Rubella
Pneumococcal
Hepatitis
COVID-19
Others
By Technology
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Adult Vaccine Market, 2025
5.2 Asia Pacific Adult Vaccine Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Adult Vaccine Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Adult Vaccine Market, 2025
5.5 Europe Adult Vaccine Market Size Outlook by Type, 2021- 2030
5.6 Europe Adult Vaccine Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Adult Vaccine Market, 2025
5.8 North America Adult Vaccine Market Size Outlook by Type, 2021- 2030
5.9 North America Adult Vaccine Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Adult Vaccine Market, 2025
5.11 South America Pacific Adult Vaccine Market Size Outlook by Type, 2021- 2030
5.12 South America Adult Vaccine Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Adult Vaccine Market, 2025
5.14 Middle East Africa Adult Vaccine Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Adult Vaccine Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Adult Vaccine Market Size Outlook and Revenue Growth Forecasts
6.2 US Adult Vaccine Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Adult Vaccine Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Adult Vaccine Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Adult Vaccine Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Adult Vaccine Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Adult Vaccine Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Adult Vaccine Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Adult Vaccine Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Adult Vaccine Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Adult Vaccine Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Adult Vaccine Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Adult Vaccine Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Adult Vaccine Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Adult Vaccine Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Adult Vaccine Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Adult Vaccine Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Adult Vaccine Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Adult Vaccine Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Adult Vaccine Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Adult Vaccine Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Adult Vaccine Industry Drivers and Opportunities
7. ADULT VACCINE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ADULT VACCINE COMPANY PROFILES
8.1 Profiles of Leading Adult Vaccine Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AstraZeneca
Bharat Biotech
Biological E Ltd
CSL Ltd
GSK plc
Indian Immunologicals Ltd
Johnson & Johnson Services Inc
Pfizer Inc
Sanofi
Serum Institute of India Pvt. Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Adult Vaccine Market Overview and Key Findings, 2024
1.2 Adult Vaccine Market Size and Growth Outlook, 2021- 2030
1.3 Adult Vaccine Market Growth Opportunities to 2030
1.4 Key Adult Vaccine Market Trends and Challenges
1.4.1 Adult Vaccine Market Drivers and Trends
1.4.2 Adult Vaccine Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Adult Vaccine Companies
2. ADULT VACCINE MARKET SIZE OUTLOOK TO 2030
2.1 Adult Vaccine Market Size Outlook, USD Million, 2021- 2030
2.2 Adult Vaccine Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ADULT VACCINE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ADULT VACCINE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Monovalent
multivalent
By Application
Influenza
Tetanus/Diphtheria/Pertussis
Varicella
Human Papillomavirus
Zoster
Measles/mumps/Rubella
Pneumococcal
Hepatitis
COVID-19
Others
By Technology
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Adult Vaccine Market, 2025
5.2 Asia Pacific Adult Vaccine Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Adult Vaccine Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Adult Vaccine Market, 2025
5.5 Europe Adult Vaccine Market Size Outlook by Type, 2021- 2030
5.6 Europe Adult Vaccine Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Adult Vaccine Market, 2025
5.8 North America Adult Vaccine Market Size Outlook by Type, 2021- 2030
5.9 North America Adult Vaccine Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Adult Vaccine Market, 2025
5.11 South America Pacific Adult Vaccine Market Size Outlook by Type, 2021- 2030
5.12 South America Adult Vaccine Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Adult Vaccine Market, 2025
5.14 Middle East Africa Adult Vaccine Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Adult Vaccine Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Adult Vaccine Market Size Outlook and Revenue Growth Forecasts
6.2 US Adult Vaccine Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Adult Vaccine Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Adult Vaccine Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Adult Vaccine Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Adult Vaccine Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Adult Vaccine Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Adult Vaccine Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Adult Vaccine Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Adult Vaccine Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Adult Vaccine Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Adult Vaccine Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Adult Vaccine Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Adult Vaccine Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Adult Vaccine Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Adult Vaccine Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Adult Vaccine Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Adult Vaccine Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Adult Vaccine Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Adult Vaccine Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Adult Vaccine Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Adult Vaccine Industry Drivers and Opportunities
7. ADULT VACCINE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ADULT VACCINE COMPANY PROFILES
8.1 Profiles of Leading Adult Vaccine Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AstraZeneca
Bharat Biotech
Biological E Ltd
CSL Ltd
GSK plc
Indian Immunologicals Ltd
Johnson & Johnson Services Inc
Pfizer Inc
Sanofi
Serum Institute of India Pvt. Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
